Home › NDC Lookup › RxCUI directory › RxCUI 999965

Glycopyrrolate 0.2 MG/ML Oral Solution [Cuvposa] — RxCUI 999965

RxNorm drug concept · Semantic branded drug
RxCUI 999965 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI999965
Official nameGlycopyrrolate 0.2 MG/ML Oral Solution [Cuvposa]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCuvposa 0.2 MG/ML Oral Solution; Cuvposa 1 MG in 5 mL Oral Solution; Cuvposa 1 MG per 5 ML Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)3,355 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Glycopyrronium Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Qbrexza is a medicated cloth you wipe under your arms once a day. It contains glycopyrronium, which blocks the signal your nerves send to your sweat glands. The result is that your...
  • What exactly is Qbrexza and what is it supposed to do?
  • Each pouch holds one pre-moistened cloth. Tear it open, unfold the cloth, and wipe it across one underarm once — then use that same cloth on your other underarm. Apply it to clean,...
  • Dry mouth is the most common one — about 1 in 4 people in trials noticed it. You might also experience blurred vision, dilated pupils, mild difficulty urinating, headache, or dryne...
📖 Read our full Glycopyrronium Topical guide →

🕸️ Concept Web — How Glycopyrrolate 0.2 MG/ML Oral Solution [Cuvposa] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Glycopyrrolate 0.2 MG/ML Oral Solution [Cuvposa] RxCUI 999965

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Glycopyrronium 1546438
    • Glycopyrrolate 4955
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cuvposa 999962
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glycopyrronium Oral Solution 999960
    • Glycopyrrolate Oral Solution 2645403
    • Glycopyrronium Oral Liquid Product 2109866
    • Glycopyrronium Oral Product 2109873
    • Glycopyrrolate Oral Liquid Product 2662792
    • Glycopyrrolate Oral Product 2661028
    • Glycopyrronium Oral Solution [Cuvposa] 999964
    • Glycopyrrolate Oral Solution [Cuvposa] 2654248
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glycopyrrolate 0.2 MG/ML Oral Solution SCD · 999961
  • Glycopyrrolate 0.2 MG/ML SCDC · 315999
  • Glycopyrronium Oral Solution SCDF · 999960
  • Glycopyrrolate Oral Solution SCDFP · 2645403
  • Glycopyrronium Oral Liquid Product SCDG · 2109866
  • Glycopyrronium Oral Product SCDG · 2109873
  • Glycopyrrolate Oral Liquid Product SCDGP · 2662792
  • Glycopyrrolate Oral Product SCDGP · 2661028

Brand-Name Concepts

  • Glycopyrrolate 0.2 MG/ML [Cuvposa] SBDC · 999963
  • Glycopyrronium Oral Solution [Cuvposa] SBDF · 999964
  • Glycopyrrolate Oral Solution [Cuvposa] SBDFP · 2654248
  • Cuvposa Oral Liquid Product SBDG · 1173727
  • Cuvposa Oral Product SBDG · 1173728
  • Cuvposa BN · 999962

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 999965 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00259-0501-16 1 BOTTLE in 1 CARTON (0259-0501-16) / 473 mL in 1 BOTTLE Cuvposa Merz Pharmaceuticals, LLC 2013-01-01
Observed labelers: Merz Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.0129
Range $1.0129–$1.0129 · middle 50% $1.0129–$1.0129 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.